Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647306 · ClinicalTrials.gov registry record · NA
Behavioral Chronotype: Impact on Sleep and Metabolism
A NA study of Cardiovascular Diseases and Type 2 Diabetes Mellitus, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03647306: Active NA study of Cardiovascular Diseases and Type 2 Diabetes Mellitus, sponsored by University of Chicago.
NCT03647306 is a NA study of Cardiovascular Diseases and Type 2 Diabetes Mellitus that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 200 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03647306, a NA study of Cardiovascular Diseases and Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine how the timing of eating changes how the body makes and uses energy (metabolism). This study will also examine if metabolism changes with age.
Primary Outcome
The primary outcome measure is the Matsuda Index of Insulin Sensitivity.
Conditions Studied
Interventions
- BEHAVIORAL Early Total Caloric Intake
- BEHAVIORAL Late Total Caloric Intake
- BEHAVIORAL Extended Overnight Fast
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What the registry record for NCT03647306 still lists
NCT03647306 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Early Total Caloric Intake is the first listed.
NCT03647306 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03647306 about?
NCT03647306 is a clinical study titled "Behavioral Chronotype: Impact on Sleep and Metabolism". The purpose of this study is to examine how the timing of eating changes how the body makes and uses energy (metabolism). This study will also examine if metabolism changes with age.
What is the current status of trial NCT03647306?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2018-02-02. Estimated completion is 2027-01-01.
What conditions does trial NCT03647306 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT03647306?
The interventions under investigation include: Early Total Caloric Intake (BEHAVIORAL), Late Total Caloric Intake (BEHAVIORAL), Extended Overnight Fast (BEHAVIORAL).
Who is sponsoring clinical trial NCT03647306?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03647306 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03647306's enrollment target sits among peer trials
200 145th of 300 higher than 146 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI